News
Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.
Modern Engineering Marvels on MSN3d
Inside Crew-10’s Science: How Space Alters Life Itself
It is one thing to understand that space alters the human body; it is another to see it happen before one’s eyes, on people ...
Discover how inflammation peptides are revolutionising our understanding of immune regulation, offering new avenues for ...
Laboratory mice are often considered the scientific equivalent of identical twins—genetically identical and expected to look ...
In its latest earnings report, Iovance confirmed plans to reduce its workforce by 19% in a bid to save $100 million in yearly ...
Medical Xpress on MSN10d
Reinvigorating exhausted T cells in cancer and chronic viral infections
Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...
4d
News-Medical.Net on MSNNew imaging technique reveals how antibodies reshape cancer cell receptors
A new study shows how the single-molecule organization of receptors in a cellular context determines the function of ...
Novel method reveals glucose channeling, charting the fine structure of energy metabolism inside active cells by Alexandra Scammell, Vanderbilt University ...
16d
Smithsonian Magazine on MSNThese Super-Resolution Microscopes Are Revealing the Inner Lives of Cells
Advanced light microscopy techniques are giving scientists a new understanding of human biology and what goes wrong in ...
PD-1 Inactivated TIL Cell Therapy (IOV-4001): Results are anticipated in the second half of 2025 from the Phase 2 efficacy portion of the IOV-GM1-201 trial in previously treated advanced melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results